These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6488692)

  • 21. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J
    Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass spectrometry in the search for uremic toxins.
    Niwa T
    Mass Spectrom Rev; 1997; 16(6):307-32. PubMed ID: 9703693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. II. Chief peptide constituents of the faction.
    Klein A; Sarnecka-Keller M; Hanicki Z
    Clin Chim Acta; 1978 Nov; 90(1):7-11. PubMed ID: 719891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separation, isolation, and identification of middle molecules.
    Bergström J; Fürst P; Zimmerman L
    Artif Organs; 1981; 4 Suppl():5-7. PubMed ID: 7295096
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation of the homogeneous constituents from non-diffusible sugar-peptide (NSP) fraction originating from bovine plasma. III. The method of isolation and partial characterization of the four peptide constituents.
    Klein A
    Folia Histochem Cytochem (Krakow); 1983; 21(1):3-14. PubMed ID: 6873768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uremic middle molecules: separation and quantitation.
    Chapman GV; Farrell PC
    Artif Organs; 1981; 4 Suppl():160-5. PubMed ID: 7295084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma middle molecules in asymptomatic and "sick" uremic patients.
    Asaba H; Bergström J; Fürst P; Johnson C; Yahiel V
    Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia.
    Brunner H; Mann H; Essers U; Schultheis R; Byrne T; Heintz R
    Artif Organs; 1978 Nov; 2(4):375-7. PubMed ID: 743009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bovine proinsulin: isolation, properties and activation by trypsin].
    Schmidt DD; Arens A
    Hoppe Seylers Z Physiol Chem; 1968 Sep; 349(9):1157-68. PubMed ID: 5706142
    [No Abstract]   [Full Text] [Related]  

  • 30. [Amino-acid composition of the fibrin self-assembly inhibitor from rat plasma and tissue].
    Byshevskiĭ ASh; Umutbaeva MK; Chiriat'ev EA
    Biokhimiia; 1984 Dec; 49(12):1934-9. PubMed ID: 6525366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane and chromatography separation techniques for the preparative isolation of uremic toxins.
    Brunner H; Mann H
    Life Support Syst; 1983; 1 Suppl 1():199-206. PubMed ID: 6336410
    [No Abstract]   [Full Text] [Related]  

  • 32. [Peptides of the "middle molecule" group].
    Galaktionov SG; Tseĭtin VM; Leonova VI; Nikolaĭchik VV; Mikhneva LM
    Bioorg Khim; 1984 Jan; 10(1):5-17. PubMed ID: 6385990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of sub-peak b4.2, middle molecule.
    Cueille G; Man NK; Sausse A; Farges JP; Funck-Brentano JL
    Artif Organs; 1981; 4 Suppl():28-32. PubMed ID: 7295091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Many hitherto unknown peptides are principal constituents of uremic "middle molecules".
    Menyhárt J; Gróf J
    Clin Chem; 1981 Oct; 27(10):1712-6. PubMed ID: 7285323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical study for separation of middle molecules.
    Saito A; Kanazawa I; Chung TG; Maeda K
    Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of middle molecule compounds.
    Zimmerman L; Jörnvall H; Bergström J; Fürst P; Sjövall J
    Artif Organs; 1981; 4 Suppl():33-6. PubMed ID: 7295092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the structure of acid alpha 1-glycoprotein. 3. Tryptic hydrolysis and separation of tryptic peptides].
    Bourrillon R; Meyer D
    Bull Soc Chim Biol (Paris); 1967; 49(8):1127-37. PubMed ID: 6053280
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of two uremic toxins by nuclear magnetic resonance and mass spectrometry.
    Monti JP; Gallice P; Braguer D; Durand C; Murisasco A; Crevat A
    Adv Exp Med Biol; 1987; 223():223-6. PubMed ID: 3447439
    [No Abstract]   [Full Text] [Related]  

  • 39. Improved method for purification of toxic peptides produced by cyanobacteria.
    Harada K; Suzuki M; Dahlem AM; Beasley VR; Carmichael WW; Rinehart KL
    Toxicon; 1988; 26(5):433-9. PubMed ID: 3142107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The search for the uremic toxin: the case for carbamoylation of amino acids and proteins.
    Kraus LM; Kraus AP
    Wien Klin Wochenschr; 1998 Aug; 110(15):521-30. PubMed ID: 9782570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.